A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1

NCT07292168 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma Metastatic
Prostate Cancer Metastatic
Non-small Cell Lung Cancer Metastatic
Breast Cancer Metastatic
Head & Neck Cancer

Interventions

BIOLOGICAL: humanized monoclonal anti-FGFR1 antibody OM-RCA-01

Sponsor

Kidney Cancer Research Bureau